Grossman S J
Department of Safety Assessment, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
J Pharmacol Methods. 1990 Nov;24(3):183-8. doi: 10.1016/0160-5402(90)90028-j.
A method was developed to facilitate the separation and quantitation of radiolabeled thyroxine in plasma for thyroxine clearance studies. Following intravenous injection of radioactive thyroxine, the radiolabeled thyroid hormones were isolated from plasma protein and polar metabolites by solid phase extraction on a C18 sorbent bed. The individual thyroid hormones were then separated by ion-pair reversed phase chromatography and sequentially eluted through a UV detector and radiochromatographic detector. The radioactivity of individual radiolabeled thyroid hormones was corrected for recovery of carrier as determined from UV absorbance. The recoveries of thyroxine and 3,5,3'-triiodothyronine (T3) were 96% and 101%, respectively.
已开发出一种方法,用于在甲状腺素清除率研究中促进血浆中放射性标记甲状腺素的分离和定量。静脉注射放射性甲状腺素后,通过在C18吸附剂床上进行固相萃取,从血浆蛋白和极性代谢物中分离出放射性标记的甲状腺激素。然后通过离子对反相色谱法分离各个甲状腺激素,并依次通过紫外检测器和放射性色谱检测器洗脱。根据紫外吸光度确定的载体回收率,对各个放射性标记甲状腺激素的放射性进行校正。甲状腺素和3,5,3'-三碘甲状腺原氨酸(T3)的回收率分别为96%和101%。